TILT Holdings (TLLTF) Total Non-Current Liabilities (2021 - 2025)

TILT Holdings (TLLTF) reported Total Non-Current Liabilities of $200.6 million for Q2 2025, up 16.41% on a YoY basis from $172.3 million in Q2 2024, and little changed quarter-over-quarter from $199.9 million in Q1 2025.

TILT Holdings (TLLTF) Total Non-Current Liabilities (2021 - 2025) Analysis & Trends

TILT Holdings has reported Total Non-Current Liabilities for 5 years, with the latest figure at $200.6 million in Q2 2025.

  • For the quarter ending Q2 2025, Total Non-Current Liabilities rose 16.41% year-over-year to $200.6 million; the trailing twelve-month figure through Jun 2025 stood at $200.6 million (up 16.41% YoY), and the FY2024 full-year result was $188.2 million, up 12.19% from the prior year.
  • Total Non-Current Liabilities for Q2 2025 stood at $200.6 million, roughly flat from $199.9 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $200.6 million in Q2 2025, with the low at $153.3 million in Q4 2021.
  • Historically, Total Non-Current Liabilities has averaged $176.4 million across 5 years, with a median of $172.2 million in 2022.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities decreased 13.63% — and 2025, when it advanced 16.41%.
  • TILT Holdings' Total Non-Current Liabilities stood at $153.3 million in 2021, then advanced by 12.33% to $172.2 million in 2022, then dropped by 2.58% to $167.7 million in 2023, then gained by 12.19% to $188.2 million in 2024, then gained by 6.58% to $200.6 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $200.6 million (Q2 2025), $199.9 million (Q1 2025), and $188.2 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 TILT Holdings - - 1.82 Mn 200.56 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 200.56 Mn
Mar 31, 2025 199.95 Mn
Dec 31, 2024 188.18 Mn
Sep 30, 2024 177.66 Mn
Jun 30, 2024 172.29 Mn
Mar 31, 2024 178.10 Mn
Dec 31, 2023 167.74 Mn
Sep 30, 2023 165.86 Mn
Jun 30, 2023 165.46 Mn
Mar 31, 2023 166.04 Mn
Dec 31, 2022 172.19 Mn
Sep 30, 2022 170.53 Mn
Jun 30, 2022 191.56 Mn
Dec 31, 2021 153.29 Mn